GW483100

GW483100 · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW483100, covering 2017-05-09 to 2017-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions [Phase 1]